Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2017 | ‘It’s all about checkpoint inhibitors’ – Rob Jones on bladder cancer during ASCO 2017

Rob Jones, MD, University of Glasgow, UK gives us a neat round up of the important bladder cancer data being presented at ASCO 2017 as well as how physicians might use these data to inform their practice going forward. He discusses data from the pembrolizumab KEYNOTE-45 study and a study combining the PD1 checkpoint inhibitor with a novel IDO inhibitor.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.